25.5-5-516. Serious mental illness - prescribed drugs

25.5-5-516. Serious mental illness - prescribed drugs. Notwithstanding any provisions of this part 5 to the contrary, and subject to any necessary federal authorization, the state board shall require a review for coverage of a new drug approved by the federal food and drug administration for a serious mental illness within ninety days after the approval of the drug.